Georgian police yesterday arrested a top opposition leader and used tear gas in a violent raid on his party headquarters, further deepening a political crisis sparked by last year’s disputed parliamentary elections.
Live television footage showed Nika Melia, the leader of the United National Movement (UNM), the country’s main opposition party, being dragged from party headquarters to be placed in pre-trial detention.
Meanwhile, hundreds of riot police used tear gas against his supporters and the leaders of all of the country’s opposition parties, who have been camped out in the building since Wednesday last week, the live pictures on Mtavari TV showed. Scores of opposition supporters were detained.
One of the UNM leaders, Giorgi Pataraia, said that police “stole computer servers” from party headquarters.
The Georgian Ministry of the Interior said in a statement that “police used proportional force and special means” in the police operation.
“Shocked by the scenes at UNM headquarters this morning,” British Ambassador Mark Clayton to Georgia wrote on Twitter.
“Violence and chaos in Tbilisi are the last thing Georgia needs right now. I urge all sides to act with restraint, now and in the coming days,” he wrote.
Georgia has been in the grip of a political crisis since the October parliamentary elections, which opposition parties have denounced as rigged after the ruling Georgian Dream party claimed victory.
On Thursday, Giorgi Gakharia resigned as prime minister over Georgian Dream’s plans to arrest Melia.
News of the plan sparked outrage among the opposition and warnings from Georgia’s Western allies.
Last week, a court in Tbilisi ordered Melia placed in pre-trial detention after he refused to pay an increased bail fee ahead of hearings in a case related to anti-government demonstrations in 2019. He has been charged with “organizing mass violence” during the protests and faces up to nine years in prison.
Melia, 41, rejects the case as politically motivated.
Opposition members have refused to take up their seats in the new parliament. They have demanded a new poll.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very